| Time | Session |
|---|
|
5:45 p.m.
6:45 p.m.
|
ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY
WCN24-AB-1414, Poster Board= MON-089
Jonathan Barratt
Poster Presenter
|
IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY
WCN24-AB-912, Poster Board= MON-090
Jonathan Barratt
Poster Presenter
|
ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19
WCN24-AB-342, Poster Board= MON-091
Jonathan Barratt
Poster Presenter
|
MORTALITY FROM GLOMERULAR DISEASES IN BRAZIL: AN EPIDEMIOLOGICAL ANALYSIS FROM 2011 TO 2021
WCN24-AB-2367, Poster Board= MON-092
Geraldo Bezerra Da Silva Junior
Poster Presenter
|
OPTIMIZING RENAL BIOPSY SAFETY: A PROTOCOL ADDRESSING BLEEDING RISK FACTORS WITH LOW COMPLICATION RATES
WCN24-AB-1444, Poster Board= MON-093
Valeria Brozzi
Poster Presenter
|
ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY WITH CONCOMITANT MALIGNANCY AND LITERATURE REVIEW
WCN24-AB-2320, Poster Board= MON-094
Hong Cheng
Poster Presenter
|
Worldwide Use of Sodium Glucose Co-transporter 2 Inhibitors in Immunoglobulin A nephropathy: A country and Regional Analysis
WCN24-AB-1354, Poster Board= MON-095
Chee Kay Cheung
Poster Presenter
|
ASSOCIATION OF THE POLYMORPHISMS OF THE ANGIOTENSIN-CONVERTING ENZYME GENES AND FRMD3 IN THE DEVELOPMENT OF DIABETIC KIDNEY DISEASE IN THE MEXICAN POPULATION.
WCN24-AB-312, Poster Board= MON-096
Juan Daniel Diaz Garcia
Poster Presenter
|
EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
WCN24-AB-1766, Poster Board= MON-097
Hiddo Lambers Heerspink
Poster Presenter
|
KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
WCN24-AB-2606, Poster Board= MON-098
Leonel Langellotti
Poster Presenter
|
BIOPSY-PROVEN KIDNEY DISEASES IN THE ELDERLY: A STUDY IN MEXICAN POPULATION
WCN24-AB-1463, Poster Board= MON-099
Jessica Lázaro
Poster Presenter
|
BI-FUNCTIONAL C5 ANTIBODY-FUSION PROTEIN (LP-005) WITH POTENTIAL BEST-IN-CLASS BIOACTIVITY FOR COMPLEMENT INHIBITION
WCN24-AB-2025, Poster Board= MON-100
Heng Liu
Poster Presenter
|
JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
WCN24-AB-186, Poster Board= MON-101
Mateus Luvizotto
Poster Presenter
|
NATURAL HISTORY OF PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: HOW DOES 1-YEAR PROTEINURIA CORRELATE WITH LONG-TERM RENAL OUTCOME?
WCN24-AB-2379, Poster Board= MON-102
Maddalena Marasa
Poster Presenter
|
RESPONSE TO TREATMENT IN MEN WITH LUPUS NEPHRITIS: A STUDY IN MEXICAN POPULATION
WCN24-AB-1468, Poster Board= MON-103
Margarita Marlene Padilla Morales
Poster Presenter
|
OUTCOMES OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
WCN24-AB-1000, Poster Board= MON-104
Narayan Prasad
Poster Presenter
|
CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA
WCN24-AB-2435, Poster Board= MON-105
Lucas Raul Ramos
Poster Presenter
|
Towards an IgA Nephropathy Atlas
WCN24-AB-1863, Poster Board= MON-106
Julio Saez-Rodriguez
Poster Presenter
|
HISTOPATHOLOGICAL FINDINGS IN THE RENAL BIOPSY OF NATIVE KIDNEYS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2-DM)
WCN24-AB-685, Poster Board= MON-107
Ricardo Silvariño
Poster Presenter
|
End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)
WCN24-AB-1268, Poster Board= MON-108
John Sim
Poster Presenter
|
COMPARATIVE ANALYSIS OF INTERNATIONAL IGAN PREDICTION TOOL SCORES DURING TIME OF BIOPSY AND ONE-YEAR POST-BIOPSY IN PREDICTING RENAL OUTCOMES AMONG FILIPINO PATIENTS WITH IGA NEPHROPATHY
WCN24-AB-2046, Poster Board= MON-109
Jan Joel Simpauco
Poster Presenter
|
BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY
WCN24-AB-1837, Poster Board= MON-110
Hernan Trimarchi
Poster Presenter
|
SAFETY AND EFFICACY OF ANIFROLUMAB IN IMMUNE COMPLEX AND APOL-1 ASSOCIATED LUPUS PODOCYTOPATHY
WCN24-AB-420, Poster Board= MON-111
James Tumlin
Poster Presenter
|
A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE.
WCN24-AB-1780, Poster Board= MON-112
Mariana Ursino
Poster Presenter
|
IL-1? and NLRP3 gene expression profile with dapagliflozin in inactive Lupus Nephritis
WCN24-AB-1358, Poster Board= MON-113
Gisele Vajgel Fernandes
Poster Presenter
|
Treatment decision-making modle for IgA nephropathy: a real-world study
WCN24-AB-733, Poster Board= MON-114
Ying Zheng
Poster Presenter
|